Using Technology to Reduce Youth Substance Use

Drug Use Clinical Trial

— TEXT2  

Official title:

Using Technology to Reduce Youth Substance Use

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04446910
• Other study ID #: 1K24DA046569-01A1
• Secondary ID: 1K24DA046569-01A
• Status: Recruiting
• Phase: N/A
• Start date: May 1, 2020
• Est. completion date: April 1, 2024

Study information

• Verified date: December 2023
• Source: University of California, San Francisco
• Contact: Marina Tolou-Shams, PhD
• Phone: 628-206-2212
• Email: marina.tolou-shams[@]ucsf.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.

Description:

The study will demonstrate how delivery of motivational/coaching messages to justice-involved youth and their caregivers will lead to greater youth substance use treatment attendance and engagement. The study will start with identifying the feasibility and acceptability of the SMS text-messaging intervention with community-supervised justice-involved youth. Then, the study will determine whether the tailored dyadic (youth and caregiver) SMS text-messaging intervention improves justice-involved youth substance use or dual diagnosis treatment attendance and engagement relative to standard of care (not receiving motivational/coaching messages). Finally, the study will characterize patterns of key justice and behavioral health system-level factors that promote or hinder eventual adoption and sustainability of mHealth technology as a tool to improve treatment attendance for justice-involved youth.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 162
• Est. completion date: April 1, 2024
• Est. primary completion date: April 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 13 Years to 18 Years

Eligibility

Inclusion Criteria:

• English-speaking youth with willing adult caregiver

• Ages 13-18

• Justice-involved while living in the community

• Own a mobile phone or tablet

• Are willing to send and receive text messages

• Are referred to community-based substance use and/or mental health treatment

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Drug Use
• Substance-Related Disorders

Intervention

Behavioral:
• SMS Text Messaging
SMS text messaging intervention for a period of 90 days to promote attendance at community-based substance use or dual diagnosis treatment appointments through motivational messages.
• Standard of Care Engagement Practices
Standard of care engagement practices, such as communicating with youth and caregivers, as needed, through texting but frequency of contact and content of messaging varies according to individual needs.

Locations

Country	Name	City	State
United States	UCSF Zuckerberg San Francisco General Hospital	San Francisco	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, San Francisco	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Alcohol use	The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) alcohol use.	90 days post baseline
Other	Alcohol use	The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) alcohol use.	180 days post baseline
Other	Drug use	The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use.	90 days post baseline
Other	Drug use	The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use.	180 days post baseline
Other	Drug Use	The Texas Christian University (TCU) Drug Screen with Opioid Supplement is used to gather detailed information about drug and opioid use.	90 days post baseline
Other	Drug Use	The Texas Christian University (TCU) Drug Screen with Opioid Supplement is used to gather detailed information about drug and opioid use.	180 days post baseline
Other	Response rate to SMS messages	Digital (mobile) health metrics	30 days post baseline
Other	Response rate to SMS messages	Digital (mobile) health metrics	60 days post baseline
Other	Response rate to SMS messages	Digital (mobile) health metrics	90 days post baseline
Other	Psychiatric symptoms	Global Appraisal of Individual Needs-Short Screener (GAIN-SS) is used to identify people with recent and lifetime internalizing and externalizing mental health disorders, substance use disorders and crime/violence problems. GAIN-SS responses are given in terms of the recency of the problem described in the questions: 3 = past month; 2 = 2 to 12 months ago; 1 = 1+ years ago; 0 = never. The number of past-month symptoms (number of 3s) is used as a measure of change; the number of past-year symptoms (number of 3s or 2s) is used to identify who is likely to have a current diagnosis; and the number of lifetime symptoms (number of 3s, 2s, or 1s) is used as a covariate measure of lifetime severity.	90 days post baseline
Other	Psychiatric symptoms	Global Appraisal of Individual Needs-Short Screener (GAIN-SS) is used to identify people with recent and lifetime internalizing and externalizing mental health disorders, substance use disorders and crime/violence problems. GAIN-SS responses are given in terms of the recency of the problem described in the questions: 3 = past month; 2 = 2 to 12 months ago; 1 = 1+ years ago; 0 = never. The number of past-month symptoms (number of 3s) is used as a measure of change; the number of past-year symptoms (number of 3s or 2s) is used to identify who is likely to have a current diagnosis; and the number of lifetime symptoms (number of 3s, 2s, or 1s) is used as a covariate measure of lifetime severity.	180 days post baseline
Other	Therapeutic Alliance	The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.	30 days post baseline
Other	Therapeutic Alliance	The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.	60 days post baseline
Other	Therapeutic Alliance	The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.	90 days post baseline
Other	Therapeutic Alliance	The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.	120 days post baseline
Other	Therapeutic Alliance	The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.	180 days post baseline
Other	Treatment Motivation	The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.	30 days post baseline
Other	Treatment Motivation	The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.	60 days post baseline
Other	Treatment Motivation	The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.	90 days post baseline
Other	Treatment Motivation	The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.	120 days post baseline
Other	Treatment Motivation	The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.	180 days post baseline
Other	Characteristics of Communication and Interaction with Probation Officers and Treatment Providers	Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.	30 days post baseline
Other	Characteristics of Communication and Interaction with Probation Officers and Treatment Providers	Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.	60 days post baseline
Other	Characteristics of Communication and Interaction with Probation Officers and Treatment Providers	Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.	90 days post baseline
Other	Characteristics of Communication and Interaction with Probation Officers and Treatment Providers	Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.	120 days post baseline
Other	Characteristics of Communication and Interaction with Probation Officers and Treatment Providers	Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.	180 days post baseline
Primary	Treatment session attendance	Proportion of treatment sessions attended	30 days post baseline
Primary	Treatment session attendance	Proportion of treatment sessions attended	60 days post baseline
Primary	Treatment session attendance	Proportion of treatment sessions attended	90 days post baseline
Primary	Treatment session attendance	Proportion of treatment sessions attended	120 days post baseline
Primary	Treatment session attendance	Proportion of treatment sessions attended	180 days post baseline
Secondary	First treatment session initiation	Proportion who attended first treatment session, as scheduled	120 days post baseline
Secondary	First treatment session initiation	Proportion who attended first treatment session, as scheduled	180 days post baseline